Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on ALT
    Thinking about buying stock in Ocugen, Ceragon Networks, Gannett, Altimmune, or Nio?
    9:31a ET April 1 '24 PR Newswire

    InvestorsObserver issues critical PriceWatch Alerts for OCGN, CRNT, GCI, ALT, and NIO.

    https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

    To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

    -- OCGN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=OCGN&prnumber=202404010

    -- CRNT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CRNT&prnumber=202404010

    -- GCI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=GCI&prnumber=202404010

    -- ALT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ALT&prnumber=202404010

    -- NIO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=NIO&prnumber=202404010

    (Note: You may have to copy this link into your browser then press the [ENTER] key.)

    InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

    InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

    https://c212.net/c/img/favicon.png?sn=CG76420&sd=2024-04-01

    View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-ocugen-ceragon-networks-gannett-altimmune-or-nio-302104483.html

    SOURCE InvestorsObserver

    https://rt.newswire.ca/rt.gif?NewsItemId=CG76420&Transmission_Id=202404010931PR_NEWS_USPR_____CG76420&DateId=20240401

    COMTEX_450175820/1005/2024-04-01T09:31:25

    Altimmune to Participate at Two Upcoming Conferences
    7:30a ET May 1 '24 GlobeNewswire
    Altimmune Statement on the Passing of Dr. Stephen Harrison
    5:25p ET April 25 '24 GlobeNewswire
    Thinking about buying stock in Ocugen, Ceragon Networks, Gannett, Alt...
    9:31a ET April 1 '24 PR Newswire
    Altimmune Announces Positive Lean Mass Preservation Data for Pemvidut...
    7:00a ET March 27 '24 GlobeNewswire
    Altimmune to Report Fourth Quarter and Full Year 2023 Financial Resul...
    7:30a ET March 20 '24 GlobeNewswire
    Thinking about buying stock in SoundHound AI, Intuitive Machines, Iov...
    9:31a ET March 19 '24 PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf o...
    12:01p ET March 9 '24 ACCESSWIRE
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf o...
    4:36p ET March 7 '24 GlobeNewswire
    ROSEN, A LONGSTANDING LAW FIRM, Encourages Altimmune, Inc. Investors ...
    5:30p ET March 5 '24 PR Newswire
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf o...
    4:10p ET March 5 '24 Newsfile Corp

    Market data provided by News provided by